Medical Genetics Institute
Welcome,         Profile    Billing    Logout  
 1 Trial 
7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nguyen, Lan Hieu
NCT06167460: Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

Recruiting
N/A
50
RoW
Gene Solutions
Non Small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IIIC Non-Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, Tyrosine Kinase Inhibitors
11/25
12/25
Nguyen, Sinh D
NCT06167460: Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

Recruiting
N/A
50
RoW
Gene Solutions
Non Small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IIIC Non-Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, Tyrosine Kinase Inhibitors
11/25
12/25
NCT06227728: Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Recruiting
N/A
50
RoW
Gene Solutions
Non Small Cell Lung Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Liver Cancer, Advanced Cancer, Immune Checkpoint Inhibitor
12/26
12/26
NCT06087120: Investigate the Prognostic and Predictive Value of ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

Recruiting
N/A
75
RoW
Gene Solutions
Breast Cancer Female, Stage II Breast Cancer, Stage III Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer
12/25
12/25
Tu, Lan NL
NCT06227728: Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Recruiting
N/A
50
RoW
Gene Solutions
Non Small Cell Lung Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Liver Cancer, Advanced Cancer, Immune Checkpoint Inhibitor
12/26
12/26
NCT06087120: Investigate the Prognostic and Predictive Value of ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

Recruiting
N/A
75
RoW
Gene Solutions
Breast Cancer Female, Stage II Breast Cancer, Stage III Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer
12/25
12/25
Tran, Le Son
K-ACCELERATE, NCT06391749: Clinical Validation of an MCED Test in Symptomatic Populations

Recruiting
N/A
1000
RoW
Gene Solutions, University of Medicine and Pharmacy at Ho Chi Minh City
Cancer Colon, Cancer, Liver, Cancer, Lung, Cancer, Breast, Cancer, Gastric
05/25
11/25

Download Options